Abyrx, Inc. - formerly Orthocon, Inc.
Abyrx was created in 2013 with its acquisition of the HEMASORB Resorbable Hemostatic Bone Putty portfolio and the right to develop Bezwada Biomedical’s polymer technology for bone applications.
The Company develops, manufactures, and provides therapeutic devices for use during surgical procedures.
Abyrx is privately-held and located in Irvington, NY. The Company's products are protected by over 40 issued and pending patents